`
`UNITED STATES PATENT AND TRADEMARK OFFICE
`
` __________________________________________________________________
`
`BEFORE THE PATENT TRIAL AND APPEAL BOARD
`
`
`
`FRESENIUS KABI USA, INC. and FRESENIUS KABI SWISSBIOSIM GmbH
`Petitioner,
`
`
`v.
`
`
`AMGEN, INC. and AMGEN MANUFACTURING LIMITED
`Patent Owner.
`
`
`IPR2020-00314
`
`Patent No. 9,856,287
`
`Title: REFOLDING PROTEINS USING A CHEMICALLY CONTROLLED
`REDOX STATE
`
`
`
`PETITIONERS’ UPDATED MANDATORY NOTICES
`
`Mail Stop PATENT BOARD
`Patent Trial and Appeal Board
`United States Patent and Trademark Office
`P.O. Box 1450
`Alexandria, VA 22313-1450
`
`
`
`
`
`
`
`
`
`Petitioners hereby submit the following updated mandatory notices in
`
`connection with the above captioned inter partes review of U.S. Patent No.
`
`9,856,287.
`
`A. Real Party-In-Interest (No Change)
`The real parties in interest are Fresenius Kabi USA, LLC, Fresenius Kabi
`
`SwissBioSim GmbH, Fresenius Kabi AG, Fresenius Kabi Pharmaceuticals
`
`Holding, Inc., Fresenius Kabi Deutschland GmbH, Fresenius SE & Co. KGaA, Dr.
`
`Reddy’s Laboratories, Ltd., Dr. Reddy’s Laboratories, S.A., and Dr. Reddy
`
`Laboratories Inc.
`
`B. Related Matters (Updated)
`The ’287 patent is not currently the subject of any district court litigation. U.S.
`
`Patent Application 15/889,559 is pending and claims priority to the ’287 patent.
`
`The ’287 patent is a continuation of pending U.S. Patent Applications 14/611,037
`
`and 14/793,590.
`
`There are no currently pending Patent Trial and Appeal Board (“PTAB”)
`
`proceedings that address the validity of the ’287 patent. The Board instituted
`
`PGR2019-00001, Adello Biologics, LLC v. Amgen Inc. et al. (“the Adello PGR”),
`
`which challenged the ’287 patent, on April 19, 2019, and subsequently terminated
`
`the proceeding on December 6, 2019 due to settlement between the parties.
`
`PGR2019-00001, Paper 28 (PTAB Dec. 6, 2019). Before the Adello PGR was
`
`
`
`
`
`
`
`instituted, Petitioners filed a previous IPR petition challenging the ’287 patent, but
`
`the Board found that the petition was duplicative of the then-pending but now-
`
`terminated Adello PGR, and used its discretion to deny institution under § 314(a)
`
`without evaluating the merits of the petition. Fresenius Kabi USA, LLC et al. v.
`
`Amgen, Inc. et al., IPR2019-00971, Paper 13 (PTAB Oct. 16, 2019).
`
`C. Identification of Counsel (§ 42.8(b)(3)) and Service Information
`(§ 42.8(b)(4)) (Updated)
`
`Back-Up Counsel
`Robert V. Cerwinski
`(seeking pro hac vice admission)
`Goodwin Procter LLP
`620 Eighth Avenue
`New York, NY 10018
`Tel: (212) 459-7240
`Fax: (212) 412-9078
`rcerwinski@goodwinlaw.com
`
`Back-Up Counsel
`James Breen
`(Reg. No. 75,235)
`Goodwin Procter LLP
`620 Eighth Avenue
`New York, NY 10018
`Tel: (212) 459-8835
`Fax: (212) 937-2204
`jamesbreen@goodwinlaw.com
`
`
`Lead Counsel
`
`Huiya Wu
`(Reg. No. 44,411)
`Goodwin Procter LLP
`620 Eighth Avenue
`New York, NY 10018
`Tel: (212) 459-7270
`Fax: (212) 656-1477
`hwu@goodwinlaw.com
`DG-FK287@goodwinlaw.com
`Back-Up Counsel
`Linnea P. Cipriano
`(Reg. No. 67,729)
`Goodwin Procter LLP
`620 Eighth Avenue
`New York, NY 10018
`Tel: (212) 459-7258
`Fax: (212) 937-2204
`lcipriano@goodwinlaw.com
`
`
`
`
`
`
`
`
`Back-Up Counsel
`Joshua Weinger
`
`(Reg. No. 73,198)
`Goodwin Procter LLP
`100 Northern Avenue
`Boston, MA 02210
`Tel: (617) 570-1000
`Fax: (617) 523-1231
`jweinger@goodwinlaw.com
`
`
`Back-Up Counsel
`Daryl L. Wiesen
`(seeking pro hac vice admission)
`Goodwin Procter LLP
`100 Northern Avenue
`Boston, MA 02210
`Tel: (617) 570-1000
`Fax: (617) 523-1231
`dwiesen@goodwinlaw.com
`Back-Up Counsel
`Hanna H. Yoon
`(Reg. No. 72,307)
`Fresenius Kabi USA
`Three Corporate Drive
`Lake Zurich, Illinois 60047
`Tel: (847) 550-2819
`Fax: (847) 550-7126
`hanna.yoon@fresenius-kabi.com
`
`D. Electronic Service (Updated)
`Please direct all correspondence to lead counsel and back-up counsel at the
`
`
`
`contact information above. Petitioners consent to electronic mail service at the
`
`following addresses:
`
`hwu@goodwinlaw.com
`DG-FK287@goodwinlaw.com
`rcerwinski@goodwinlaw.com
`lcipriano@goodwinlaw.com
`jamesbreen@goodwinlaw.com
`dwiesen@goodwinlaw.com
`jweinger@goodwinlaw.com
`hanna.yoon@fresenius-kabi.com
`
`
`
`
`
`
`
`Date: January 15, 2020
`
`Respectfully Submitted,
`By: /Huiya Wu/
`Huiya Wu (Reg. No. 44,411)
`Linnea Cipriano (Reg. No. 67,729)
`
`GOODWIN PROCTER LLP
`The New York Times Building
`620 Eighth Avenue
`New York, NY 10018
`(212) 813-8800 (telephone)
`(212) 355-3333 (facsimile)
`hwu@goodwinlaw.com
`DG-FK287@goodwinlaw.com
`lcipriano@goodwinlaw.com
`
`Counsel for Petitioners
`
`
`
`CERTIFICATE OF SERVICE
`
`The undersigned certifies that on the date indicated below a copy of the
`
`foregoing “PETITIONERS’ UPDATED MANDATORY NOTICES” was served
`
`on the counsel of record for the Patent Owner by filing the same through the PTAB
`
`E2E System as well as delivering a copy via electronic mail to the following
`
`addresses:
`
`sbaughman@paulweiss.com
`mraymond@paulweiss.com
`GRP-Amgen287@paulweiss.com
`
`Dated: January 15, 2020
`
`By: /Huiya Wu/
`Huiya Wu (Reg. No. 44,411)
`Linnea Cipriano (Reg. No. 67,729)
`
`GOODWIN PROCTER LLP
`The New York Times Building
`620 Eighth Avenue
`New York, NY 10018
`(212) 813-8800 (telephone)
`(212) 355-3333 (facsimile)
`hwu@goodwinlaw.com
`DG-FK287@goodwinlaw.com
`lcipriano@goodwinlaw.com
`
`Counsel for Petitioners
`
`